KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Teladoc Health (TDOC) Other Non-Current Liabilities (2016 - 2025)

Teladoc Health's Other Non-Current Liabilities history spans 12 years, with the latest figure at $643000.0 for Q4 2025.

  • For Q4 2025, Other Non-Current Liabilities fell 10.69% year-over-year to $643000.0; the TTM value through Dec 2025 reached $643000.0, down 10.69%, while the annual FY2025 figure was $643000.0, 10.69% down from the prior year.
  • Other Non-Current Liabilities for Q4 2025 was $643000.0 at Teladoc Health, down from $4.2 million in the prior quarter.
  • Across five years, Other Non-Current Liabilities topped out at $4.3 million in Q1 2025 and bottomed at $643000.0 in Q4 2025.
  • The 5-year median for Other Non-Current Liabilities is $1.5 million (2021), against an average of $1.8 million.
  • The largest annual shift saw Other Non-Current Liabilities plummeted 86.49% in 2021 before it skyrocketed 475.68% in 2025.
  • A 5-year view of Other Non-Current Liabilities shows it stood at $1.5 million in 2021, then rose by 8.45% to $1.6 million in 2022, then plummeted by 33.25% to $1.1 million in 2023, then tumbled by 33.33% to $720000.0 in 2024, then decreased by 10.69% to $643000.0 in 2025.
  • Per Business Quant, the three most recent readings for TDOC's Other Non-Current Liabilities are $643000.0 (Q4 2025), $4.2 million (Q3 2025), and $4.2 million (Q2 2025).